✦ LIBER ✦

Combination of oral idarubicin and cyclophosphamide in the treatment of advanced breast cancer

✍ Scribed by C. Wiltschke; M. Maca; T. Brodowicz; B. Valenta; C. Zielinski

Book ID: 117666159
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 151 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(98)80038-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with oral idaru

Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer

✍ Massimo Lopez; Patrizia Vici; Silvia Carpano; Maurilio Natali; Fabrizio Ganzina; 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 395 KB

Dose-finding study of the combination of

Dose-finding study of the combination of oral idarubicin and oral capecitabine in the treatment of locally advanced or advanced breast cancer

✍ F Nussey; J Afseth; E Murray; A Bowman; R Leonard; D Cameron 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Combination of oral idarubicin and predn

Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study

✍ A. Barnadas; C. Mendiola; A. Casado; A. Villar; J. Jimeno; M. Clerigue; R. Rosel 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 390 KB

Capecitabine and oral cyclophosphamide:

Capecitabine and oral cyclophosphamide: A novel oral treatment combination for advanced cancer

✍ Michael FINDLAY; Katrina SHARPLES; Greta A RILEY; Andrew SIMPSON; Stephen ACKLAN 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Combination chemotherapy with 5-Fluorour

Combination chemotherapy with 5-Fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer—an open Phase II study

✍ K. Kolarié; V. Potrebica; D. Vukas; Z. Mechl; B. Sopkova 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 483 KB

Combination chemotherapy in the treatmen

Combination chemotherapy in the treatment of advanced breast cancer

✍ Dutzu Rosner; Takuma Nemoto; Chief Thomas L. Dao 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

## Abstract Seventy‐two women with metastatic breast cancer were treated with multiple‐agent chemotherapy. Fifty women were treated with 5 drugs in combination: 5‐FU, methotrexate, vincristine, cytoxan, and prednisone; 22 were treated with the combination of 3 drugs: 5‐FU, cytoxan, and prednisone.